New defibrillator lead placement for people with leaky tricuspid valve
Part of Heart & circulation clinical trials.
This study tests a new way to place a defibrillator lead in a vein on the heart's surface, avoiding the tricuspid valve. It may help people who need a defibrillator but have a leaky tricuspid valve that could worsen with standard lead placement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need a defibrillator (ICD) or a defibrillator with heart failure therapy (CRT-D) as part of your care.
- Your doctor has found that you have at least moderate tricuspid valve regurgitation (a leaky valve) on an imaging test.
- Your doctor agrees that avoiding making the leaky valve worse is a goal for your treatment.
- Your heart's veins are suitable for this new lead placement, as seen on imaging.
- You are willing to undergo defibrillation testing (a brief test to make sure the device can shock your heart).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This study is testing a new way to place a pacemaker wire that avoids going through the tricuspid valve, which is a common area for problems. It may help people who have had or are having valve procedures.
This trial tests a way to place a pacemaker lead using a special ultrasound view through the esophagus (a transesophageal echocardiogram). The goal is to reduce the chance of developing a serious leak in the tricuspid valve caused by the pacemaker lead.
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
Hear when a new Tricuspid Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.